Regulation of TLR Signals and IBD by A20
Regulation of TLR Signals and IBD by A20
批准号:
7455300
负责人:
DAVID L. BOONE
金额:
$12.18万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-08-01 至 2009-06-30
关键词:
Cell LineageCellsDataDevelopmentEnzymesHematopoieticInflammatoryInflammatory ResponseIntestinal MucosaLigandsMAP Kinase GeneMediator of activation proteinMicrobeModificationMucositisMusNF-kappa BPathway interactionsPeptidoglycanProcessProteinsReceptor SignalingRegulationRoleSignal PathwaySignal TransductionSignaling ProteinSourceTNF geneTestingToll-like receptorsUbiquitincell typecommensal microbescytokinemacrophagemicrobialmicrobicidepathogenresponseubiquitin ligase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
The inflammatory response to microbial pathogens is initiated by mammalian Toll-like receptors (TLR) that recognize conserved components of microbes, such as LPS or peptidoglycan, and signal through NF-kB and MAPK pathways to produce microbicidal and pro-inflammatory agents. We have previously demonstrated that A20 is essential for the termination of TNF-induced NF-kB and that A20-/- mice develop IBD. More recently we have uncovered the surprising fact that A20-/- x TNFRI-/- and A20-/- x TNF-/- mice can develop IBD. This initial observation suggests that, in addition to its essential role in the regulation of TNF-induced NF-kB, A20 must be essential for the regulation of a TNF-independent process that leads to IBD. In that regard, we have found that A20-/- mice are hyper-responsive to LPS and other TLR ligands. TLR signaling involves the non-proteosomal ubiquitylation of signal transduction proteins, and we have found that A20 has enzymatic activity toward ubiquitylated proteins. Thus, our hypothesis is that modification of signal protein ubiquitylation by A20 is essential for the normal regulation of TLR-induced cellular signals and that A20 regulation of TLR signaling protects against the excessive mucosal inflammation that leads to IBD. To test this hypothesis we will: (1) Examine the TNF-independent role of A20 in IBD; (2) Examine the role of A20 regulation of TLR signals in IBD and (3) Determine whether and how A20 acts as an essential regulator of TLR signaling
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A role for the stomach in protection from colitis
-
批准号:10153780
-
项目类别:
-
资助金额:$50.66万
-
财政年份:2020
-
负责人:DAVID L. BOONE
-
依托单位:
A role for the stomach in protection from colitis
-
批准号:10339428
-
项目类别:
-
资助金额:$50.66万
-
财政年份:2020
-
负责人:DAVID L. BOONE
-
依托单位:
A role for the stomach in protection from colitis
-
批准号:10552043
-
项目类别:
-
资助金额:$50.66万
-
财政年份:2020
-
负责人:DAVID L. BOONE
-
依托单位:
Gastric control of the Intestinal Microbiome and Obesity
-
批准号:9164925
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2016
-
负责人:DAVID L. BOONE
-
依托单位:
Functional consequences of autophagy mutations in Crohn's disease.
-
批准号:8100343
-
项目类别:
-
资助金额:$33.87万
-
财政年份:2009
-
负责人:DAVID L. BOONE
-
依托单位:
Functional consequences of autophagy mutations in Crohn's disease.
-
批准号:8306227
-
项目类别:
-
资助金额:$33.87万
-
财政年份:2009
-
负责人:DAVID L. BOONE
-
依托单位:
Functional consequences of autophagy mutations in Crohn's disease.
-
批准号:7699219
-
项目类别:
-
资助金额:$26.76万
-
财政年份:2009
-
负责人:DAVID L. BOONE
-
依托单位:
Functional consequences of autophagy mutations in Crohn's disease.
-
批准号:7901443
-
项目类别:
-
资助金额:$34.22万
-
财政年份:2009
-
负责人:DAVID L. BOONE
-
依托单位:
Regulation of TLR Signals and IBD by A20
-
批准号:7273513
-
项目类别:
-
资助金额:$12.18万
-
财政年份:2005
-
负责人:DAVID L. BOONE
-
依托单位:
Regulation of TLR Signals and IBD by A20
-
批准号:7102701
-
项目类别:
-
资助金额:$12.29万
-
财政年份:2005
-
负责人:DAVID L. BOONE
-
依托单位:
Regulation of TLR Signals and IBD by A20
-
批准号:6966480
-
项目类别:
-
资助金额:$2.34万
-
财政年份:2005
-
负责人:DAVID L. BOONE
-
依托单位:
Regulation of TLR Signals and IBD by A20
-
批准号:7235970
-
项目类别:
-
资助金额:$9.84万
-
财政年份:2005
-
负责人:DAVID L. BOONE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:肖将尉
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
-
批准号:82070825
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2020
-
负责人:徐西振
-
依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
-
批准号:81903002
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:王斐斐
-
依托单位:
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
-
批准号:81402419
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:杨翠霞
-
依托单位:
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
-
批准号:81271563
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:陈正光
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
-
批准号:31271248
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:李伟
-
依托单位:
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
-
批准号:81160050
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2011
-
负责人:邵立健
-
依托单位: